Drug & intervention

Stribild

RxCUI 1306293

Clinical trials12

Recruiting0

Related conditions7

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

12 shown

Interaction With HIV Antiretroviral AgentsNCT02556268 · 2016-02-23

Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected IndividualsNCT02251236 · 2016-01-01

Bioequivalence of Crushed Stribild With a Normal Breakfast or With Drip Feed Compared to the Whole TabletNCT02325934 · 2015-02-01

Atripla to Stribild Switch Study to Evaluate Sleep DisturbancesNCT02477527 · 2015-02-01

STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY)NCT02306577 · 2014-11-01

Sleep and Cognition After Atripla to Stribild SwitchNCT02283060 · 2014-09-01

Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected PatientsNCT01533259 · 2012-01-01

Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected PatientsNCT01495702 · 2011-12-01

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected PatientsNCT01475838 · 2011-11-01

Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsNCT01106586 · 2010-04-01

Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsNCT01095796 · 2010-03-01

Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsNCT00869557 · 2009-04-01

Conditions being studied

HIV8 HIV Infections6 Acquired Immunodeficiency Syndrome3 AIDS1 HIV-DDI1 Illicit Drug User1 Sleep Disorders1

Research locations

OrlandoFlorida, United States7 HoustonTexas, United States6 Los AngelesCalifornia, United States6 Washington D.C.District of Columbia, United States6 DallasTexas, United States5 Fort LauderdaleFlorida, United States5 San DiegoCalifornia, United States5 San FranciscoCalifornia, United States5 AtlantaGeorgia, United States4 Beverly HillsCalifornia, United States4 BostonMassachusetts, United States4 CharlotteNorth Carolina, United States4

Leading sponsors

Gilead Sciences6 Bayer1 Midtown Medical Center, Tampa, FL1 Radboud University Medical Center1 University of California, San Diego1 University of Hawaii1 Vancouver Infectious Diseases Centre1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.